The multi-factorial nature of clinical multidrug resistance in cancer
Curative cancer therapy remains a major challenge particularly in cancers displaying
multidrug resistance (MDR). The MDR phenotype is characterized by cross-resistance to a …
multidrug resistance (MDR). The MDR phenotype is characterized by cross-resistance to a …
Extracellular vesicles as tools and targets in therapy for diseases
Extracellular vesicles (EVs) are nano-sized, membranous structures secreted into the
extracellular space. They exhibit diverse sizes, contents, and surface markers and are …
extracellular space. They exhibit diverse sizes, contents, and surface markers and are …
Long non-coding RNAs in the doxorubicin resistance of cancer cells
S Ashrafizaveh, M Ashrafizadeh, A Zarrabi… - Cancer Letters, 2021 - Elsevier
Chemotherapy is the main treatment used for cancer patients failing surgery. Doxorubicin
(DOX) is a well-known chemotherapeutic agent capable of suppressing proliferation in …
(DOX) is a well-known chemotherapeutic agent capable of suppressing proliferation in …
DRESIS: the first comprehensive landscape of drug resistance information
X Sun, Y Zhang, H Li, Y Zhou, S Shi… - Nucleic acids …, 2023 - academic.oup.com
Widespread drug resistance has become the key issue in global healthcare. Extensive
efforts have been made to reveal not only diverse diseases experiencing drug resistance …
efforts have been made to reveal not only diverse diseases experiencing drug resistance …
Exosomes and breast cancer drug resistance
Drug resistance is a daunting challenge in the treatment of breast cancer (BC). Exosomes,
as intercellular communicative vectors in the tumor microenvironment, play an important role …
as intercellular communicative vectors in the tumor microenvironment, play an important role …
Nano-drug delivery system targeting tumor microenvironment: a prospective strategy for melanoma treatment
M Xu, S Li - Cancer Letters, 2023 - Elsevier
Melanoma, the most aggressive form of cutaneous malignancy arising from melanocytes, is
frequently characterized by metastasis. Despite considerable progress in melanoma …
frequently characterized by metastasis. Despite considerable progress in melanoma …
[HTML][HTML] Small extracellular vesicles in cancer
Extracellular vesicles (EV) are lipid-bilayer enclosed vesicles in submicron size that are
released from cells. A variety of molecules, including proteins, DNA fragments, RNAs, lipids …
released from cells. A variety of molecules, including proteins, DNA fragments, RNAs, lipids …
MALDI-IHC-guided in-depth spatial proteomics: targeted and untargeted MSI combined
Recently, a novel technology was published, utilizing the strengths of matrix-assisted laser
desorption/ionization (MALDI) mass spectrometry imaging (MSI) and immunohistochemistry …
desorption/ionization (MALDI) mass spectrometry imaging (MSI) and immunohistochemistry …
Microfluidics for detection of exosomes and microRNAs in cancer: State of the art
SM Mousavi, SMA Mahdian, MS Ebrahimi… - … Therapy-Nucleic Acids, 2022 - cell.com
Exosomes are small extracellular vesicles with sizes ranging from 30–150 nanometers that
contain proteins, lipids, mRNAs, microRNAs, and double-stranded DNA derived from the …
contain proteins, lipids, mRNAs, microRNAs, and double-stranded DNA derived from the …
The key roles of cancer stem cell-derived extracellular vesicles
C Su, J Zhang, Y Yarden, L Fu - Signal transduction and targeted …, 2021 - nature.com
Cancer stem cells (CSCs), the subpopulation of cancer cells, have the capability of
proliferation, self-renewal, and differentiation. The presence of CSCs is a key factor leading …
proliferation, self-renewal, and differentiation. The presence of CSCs is a key factor leading …